Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial.
Saved in:
| Title: | Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial. |
|---|---|
| Authors: | Bautista F; Hospital Niño Jesús, Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Madrid, Spain., Paoletti X; Gustave Roussy Cancer Campus, Biostatistics and Epidemiology Unit, INSERM U1018, CESP, Université Paris-Saclay, UVSQ, Villejuif, France.; Current address: Institut Curie, INSERM U900 STAMPM, UVSQ, St Cloud, France., Rubino J; Gustave Roussy Cancer Campus, Clinical Research Direction, Villejuif, France., Brard C; Gustave Roussy Cancer Campus, Biostatistics and Epidemiology Unit, INSERM U1018, CESP, Université Paris-Saclay, UVSQ, Villejuif, France., Rezai K; Institut Curie, Radio-Pharmacology Department, Saint Cloud, France., Nebchi S; Gustave Roussy Cancer Campus, Biostatistics and Epidemiology Unit, INSERM U1018, CESP, Université Paris-Saclay, UVSQ, Villejuif, France., Andre N; Department of Pediatric Oncology, Hôpital de la Timone, AP-HM, Marseille, France.; UMR Inserm 1068, CNRS UMR 7258, Aix Marseille Université U105, Marseille Cancer Research Center (CRCM), Marseille, France., Aerts I; SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Institut Curie, PSL Research University, Paris, France., De Carli E; Department of Pediatric Oncology, University Hospital, Angers, France., van Eijkelenburg N; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Thebaud E; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Nantes, France., Corradini N; Pediatric Oncology Department, Institut of Pediatric Hematology and Oncology, Centre Leon Berard, Lyon, France., Defachelles AS; Department of Pediatric Oncology, Oscar Lambret Cancer Center, Lille, France., Ducassou S; Centre Hospitalier Universitaire Pellegrin-Hôpital des Enfants, Bordeaux, France., Morscher RJ; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France.; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Vassal G; Gustave Roussy Cancer Campus, Clinical Research Direction, Villejuif, France., Geoerger B; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France.; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Nov 10; Vol. 39 (32), pp. 3546-3560. Date of Electronic Publication: 2021 Aug 04. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34347542 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bautista+F%22">Bautista F</searchLink>; Hospital Niño Jesús, Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Paoletti+X%22">Paoletti X</searchLink>; Gustave Roussy Cancer Campus, Biostatistics and Epidemiology Unit, INSERM U1018, CESP, Université Paris-Saclay, UVSQ, Villejuif, France.; Current address: Institut Curie, INSERM U900 STAMPM, UVSQ, St Cloud, France.<br /><searchLink fieldCode="AU" term="%22Rubino+J%22">Rubino J</searchLink>; Gustave Roussy Cancer Campus, Clinical Research Direction, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Brard+C%22">Brard C</searchLink>; Gustave Roussy Cancer Campus, Biostatistics and Epidemiology Unit, INSERM U1018, CESP, Université Paris-Saclay, UVSQ, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Rezai+K%22">Rezai K</searchLink>; Institut Curie, Radio-Pharmacology Department, Saint Cloud, France.<br /><searchLink fieldCode="AU" term="%22Nebchi+S%22">Nebchi S</searchLink>; Gustave Roussy Cancer Campus, Biostatistics and Epidemiology Unit, INSERM U1018, CESP, Université Paris-Saclay, UVSQ, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Andre+N%22">Andre N</searchLink>; Department of Pediatric Oncology, Hôpital de la Timone, AP-HM, Marseille, France.; UMR Inserm 1068, CNRS UMR 7258, Aix Marseille Université U105, Marseille Cancer Research Center (CRCM), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Aerts+I%22">Aerts I</searchLink>; SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22De+Carli+E%22">De Carli E</searchLink>; Department of Pediatric Oncology, University Hospital, Angers, France.<br /><searchLink fieldCode="AU" term="%22van+Eijkelenburg+N%22">van Eijkelenburg N</searchLink>; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Thebaud+E%22">Thebaud E</searchLink>; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Corradini+N%22">Corradini N</searchLink>; Pediatric Oncology Department, Institut of Pediatric Hematology and Oncology, Centre Leon Berard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Defachelles+AS%22">Defachelles AS</searchLink>; Department of Pediatric Oncology, Oscar Lambret Cancer Center, Lille, France.<br /><searchLink fieldCode="AU" term="%22Ducassou+S%22">Ducassou S</searchLink>; Centre Hospitalier Universitaire Pellegrin-Hôpital des Enfants, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Morscher+RJ%22">Morscher RJ</searchLink>; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France.; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Vassal+G%22">Vassal G</searchLink>; Gustave Roussy Cancer Campus, Clinical Research Direction, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Geoerger+B%22">Geoerger B</searchLink>; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France.; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2021 Nov 10; Vol. 39 (32), pp. 3546-3560. <i>Date of Electronic Publication: </i>2021 Aug 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34347542 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/JCO.21.01152 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3546 Titles: – TitleFull: Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bautista F – PersonEntity: Name: NameFull: Paoletti X – PersonEntity: Name: NameFull: Rubino J – PersonEntity: Name: NameFull: Brard C – PersonEntity: Name: NameFull: Rezai K – PersonEntity: Name: NameFull: Nebchi S – PersonEntity: Name: NameFull: Andre N – PersonEntity: Name: NameFull: Aerts I – PersonEntity: Name: NameFull: De Carli E – PersonEntity: Name: NameFull: van Eijkelenburg N – PersonEntity: Name: NameFull: Thebaud E – PersonEntity: Name: NameFull: Corradini N – PersonEntity: Name: NameFull: Defachelles AS – PersonEntity: Name: NameFull: Ducassou S – PersonEntity: Name: NameFull: Morscher RJ – PersonEntity: Name: NameFull: Vassal G – PersonEntity: Name: NameFull: Geoerger B IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 11 Text: 2021 Nov 10 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1527-7755 Numbering: – Type: volume Value: 39 – Type: issue Value: 32 Titles: – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Type: main |
| ResultId | 1 |
